Samantha Cunzo, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 904 Washington Rd Ste F, Westminster, MD 21157 Phone: 410-871-2990 Fax: 443-293-8703 |
Stacey Reed, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 187 E Main St, Westminster, MD 21157 Phone: 410-984-6793 |
Deborah Gosnell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3033 |
Mrs. Elizabeth W. Robinette, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 503 Tylney Hall Ct, Westminster, MD 21158 Phone: 443-244-0601 |
Tova G Lowy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3033 |
Taylor Alexis Kalkbrenner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3033 |
Emily Bankert Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3000 |
Wendy Lee O'meally Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3033 |
Mary Elizabeth Ingson, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-876-4437 |
Jacob Leonard Creitz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1413 Washington Rd, Westminster, MD 21157 Phone: 410-751-3610 |
Yin Ting Andrea Pang Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 N Court St, Westminster, MD 21157 Phone: 410-751-3033 |
Hannah Buckley, SLP-L Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 511 Jermor Ln Ste 102, Westminster, MD 21157 Phone: 410-618-1090 |
News Archive
Merck & Co have finally won the Food and Drugs Administration – FDA'S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepatitis C virus. The drug brand named, Victrelis is expected to help transform treatment of the potentially fatal disease with higher cure rates and shorter courses of therapy for some patients. Merck shares rose 0.6 percent in after-hours trading to $37.33, up from their $37.08 close on the New York Stock Exchange. Approval of Victrelis was widely expected after a FDA advisory panel recommended the drug in an 18-0 vote in April.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced it will provide pain management and therapeutic drug monitoring services to physicians participating in UnitedHealthcare's national care provider network.
Today, Lung Cancer Alliance-New England thanked Senator John Kerry (D-MA) for being an original sponsor of the Lung Cancer Mortality Reduction Act (S. 752), authorizing legislation that establishes a multi-agency, comprehensive research program addressing all aspects of lung cancer, and called on the entire delegation of Massachusetts to show their support for the lung cancer community.
Affymax, Inc. today reported financial results for the first quarter ended March 31, 2012. The net income for the first quarter of 2012 was $31.5 million (or $0.87 per share) compared to a net loss of $9.6 million (or $(0.36) per share) for the first quarter of 2011.
Team work is just as important in your brain as it is on the playing field: A new study published online on April 19 by the Proceedings of the National Academy of Sciences reports that groups of brain cells can substantially improve their ability to discriminate between different orientations of simple visual patterns by synchronizing their electrical activity.
› Verified 4 days ago